Incyte Corporation revenue by year
Over the 10 fiscal years shown, revenue went from $1.11B (year ended Dec 31, 2016) to $5.14B (year ended Dec 31, 2025), a compound annual growth rate of 18.6%. The fastest growth was +38.9% in the year ended Dec 31, 2017; the weakest year was +8.9% (year ended Dec 31, 2023).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $5.14B | +21.2% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 10, 2026 |
| Dec 31, 2024 | $4.24B | +14.8% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 10, 2026 |
| Dec 31, 2023 | $3.70B | +8.9% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 10, 2026 |
| Dec 31, 2022 | $3.39B | +13.7% | Revenues | 10-K filed Feb 7, 2023 |
| Dec 31, 2021 | $2.99B | +12.0% | Revenues | 10-K filed Feb 7, 2023 |
| Dec 31, 2020 | $2.67B | +23.5% | Revenues | 10-K filed Feb 7, 2023 |
| Dec 31, 2019 | $2.16B | +14.7% | Revenues | 10-K filed Feb 8, 2022 |
| Dec 31, 2018 | $1.88B | +22.5% | Revenues | 10-K filed Feb 9, 2021 |
| Dec 31, 2017 | $1.54B | +38.9% | Revenues | 10-K filed Feb 13, 2020 |
| Dec 31, 2016 | $1.11B | +46.7% | Revenues | 10-K filed Feb 14, 2019 |
Incyte Corporation reported revenue under 2 different XBRL concepts across these years (often after the 2018 change in revenue-recognition rules, ASC 606). Each row shows the concept used, so you can judge comparability.
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $1.56B | +14.0% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2026 | $1.67B | +37.7% | 10-Q filed Jul 28, 2026 |
| 3 months ended Mar 31, 2026 | $1.27B | +20.9% | 10-Q filed Apr 28, 2026 |
| 3 months ended Sep 30, 2025 | $1.37B | +20.0% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2025 | $1.22B | +16.5% | 10-Q filed Jul 28, 2026 |
| 3 months ended Mar 31, 2025 | $1.05B | +19.5% | 10-Q filed Apr 28, 2026 |
| 3 months ended Sep 30, 2024 | $1.14B | +23.8% | 10-Q filed Oct 28, 2025 |
| 3 months ended Jun 30, 2024 | $1.04B | +9.3% | 10-Q filed Jul 29, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 879169 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.